Yahoo Finance26d
U.S. FDA Approves AOP Health’s RapiblykTM (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting
"Rapiblyk TM approval in the US represents an important milestone for patients experiencing supraventricular tachycardia, including atrial fibrillation and atrial flutter, who need rapid and short ...
Business Wire26d
U.S. FDA Approves AOP Health’s Rapiblyk TM (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting
“Rapiblyk TM approval in the US represents an important milestone for patients experiencing supraventricular tachycardia, including atrial fibrillation and atrial flutter, who need rapid and ...
Cardiac Ablation Market To Reach $8.6 Billion, Globally, By 2033 At 9.9% CAGR: Allied Market Research
Cardiac Ablation market 2033. PORTLAND, IL, UNITED STATES, December 17, 2024 /EINPresswire / -- Allied Market Research published a report, titled, "Cardiac ...
Monthly Prescribing Reference26d
Rapiblyk Approved to Treat Supraventricular Tachycardia
for the short-term reduction of ventricular rate in adults with supraventricular tachycardia including atrial fibrillation and atrial flutter. Landiolol is a selective beta-1 adrenergic receptor ...
stockhead on MSN16h
Stocking stuffers: Morgans’ top ASX health picks for 2025
Morgans healthcare and life sciences experts Iain Wilkie and Scott Power give Stockhead readers their top picks for 2025.
GlobalData on MSN6d
Adagio Medical announces Todd Usen as new CEO and director
Olav Bergheim has stepped down from his roles as CEO and chairperson but will continue to serve as an adviser for a year.